230 related articles for article (PubMed ID: 17580273)
1. p63 Immunocytochemistry improves accuracy of diagnosis with fine-needle aspiration of the breast.
Harton AM; Wang HH; Schnitt SJ; Jacobs TW
Am J Clin Pathol; 2007 Jul; 128(1):80-5. PubMed ID: 17580273
[TBL] [Abstract][Full Text] [Related]
2. Distribution of p63, a novel myoepithelial marker, in fine-needle aspiration biopsies of the breast: an analysis of 82 samples.
Reis-Filho JS; Milanezi F; Amendoeira I; Albergaria A; Schmitt FC
Cancer; 2003 Jun; 99(3):172-9. PubMed ID: 12811858
[TBL] [Abstract][Full Text] [Related]
3. False-positives in fine-needle aspiration cytology of breast disease can be reduced with p63 immunostaining--a preliminary report.
Nagao T; Bando Y; Sasa M; Morimoto T; Sano N; Hirose T; Tangoku A
Anticancer Res; 2006; 26(6B):4373-7. PubMed ID: 17201157
[TBL] [Abstract][Full Text] [Related]
4. The Role of P63 Immunocytochemistry for Myoepithelial Cells in the Diagnosis of Atypical and Suspicious Cases in Breast Fine Needle Aspiration Cytology (FNAC).
Hafez NH; Tahoun NS
J Egypt Natl Canc Inst; 2010 Jun; 22(2):123-34. PubMed ID: 21860469
[TBL] [Abstract][Full Text] [Related]
5. Comparison of fine needle aspiration and Tru-Cut biopsy of palpable mammary lesions.
Scopa CD; Koukouras D; Spiliotis J; Harkoftakis J; Koureleas S; Kyriakopoulou D; Tzoracoleftherakis E
Cancer Detect Prev; 1996; 20(6):620-4. PubMed ID: 8939348
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic utility of CK5/6 and p63 in fine-needle aspiration of the breast lesions diagnosed as proliferative fibrocystic lesion.
Al-Maghraby H; Ghorab Z; Khalbuss W; Wong J; Silverman JF; Saad RS
Diagn Cytopathol; 2012 Feb; 40(2):141-7. PubMed ID: 22246930
[TBL] [Abstract][Full Text] [Related]
7. The role of liquid-based cytology in the investigation of breast lesions using fine-needle aspiration: a cytohistopathological evaluation.
Kontzoglou K; Moulakakis KG; Konofaos P; Kyriazi M; Kyroudes A; Karakitsos P
J Surg Oncol; 2005 Feb; 89(2):75-8. PubMed ID: 15660372
[TBL] [Abstract][Full Text] [Related]
8. Fine needle aspiration cytology of the breast. A review of 1,868 cases using the Cytospin method.
Howat AJ; Stringfellow HF; Briggs WA; Nicholson CM
Acta Cytol; 1994; 38(6):939-44. PubMed ID: 7992583
[TBL] [Abstract][Full Text] [Related]
9. Expression of p63 immunostaining in liquid-based cytology (BD SurePath) of breast fine-needle aspiration.
Osugi M; Kinoshita K; Sugita A; Kito K; Maeda T
Diagn Cytopathol; 2018 Oct; 46(10):845-852. PubMed ID: 30043485
[TBL] [Abstract][Full Text] [Related]
10. Statistical analysis of fine needle aspiration cytology of the breast. A review of 678 cases plus 4,265 cases from the literature.
Hammond S; Keyhani-Rofagha S; O'Toole RV
Acta Cytol; 1987; 31(3):276-80. PubMed ID: 3473860
[TBL] [Abstract][Full Text] [Related]
11. 'Atypical' and 'suspicious' diagnoses in breast aspiration cytology.
Kanhoush R; Jorda M; Gomez-Fernandez C; Wang H; Mirzabeigi M; Ghorab Z; Ganjei-Azar P
Cancer; 2004 Jun; 102(3):164-7. PubMed ID: 15211475
[TBL] [Abstract][Full Text] [Related]
12. Fibroadenoma masquerading carcinoma on fine-needle aspiration of the breast.
Tamiolakis D; Georgiou G; Barbagadaki S; Antoniou Ch; Nikolaidou S; Tsiminikakis N; Economou C; Bolioti S; Alifieris E
Chirurgia (Bucur); 2008; 103(2):227-30. PubMed ID: 18457104
[TBL] [Abstract][Full Text] [Related]
13. Use of p63 and CD10 in the differential diagnosis of papillary neoplasms of the breast.
de Moraes Schenka NG; Schenka AA; de Souza Queiroz L; de Almeida Matsura M; Vassallo J; Alvarenga M
Breast J; 2008; 14(1):68-75. PubMed ID: 18086274
[TBL] [Abstract][Full Text] [Related]
14. [The reliability of fine needle aspiration cytology in the diagnosis of breast cancer].
Hisamatsu K; Nomura Y; Tashiro H; Katsuta Y; Hayashi I; Sonoda F
Gan No Rinsho; 1990 Sep; 36(11):2017-22. PubMed ID: 2172583
[TBL] [Abstract][Full Text] [Related]
15. Fine-needle aspiration cytology of breast lesions: a review of cytological analysis using smooth muscle actin (SMA) immunostaining.
Sato S; Kijima H; Suto A; Yoshida H; Sato T; Shimbori M; Terasaki-Fukuzawa Y; Onoda N; Araki K; Tsuruno K; Takeshita T
Anticancer Res; 2003; 23(5b):4175-9. PubMed ID: 14666621
[TBL] [Abstract][Full Text] [Related]
16. Role of fine needle aspiration in diagnosing breast lesions.
Mansoor I; Jamal AA
Saudi Med J; 2002 Aug; 23(8):915-20. PubMed ID: 12235462
[TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical analysis of p63 and 34βE12 in fine needle aspiration cytology specimens for breast lesions: a potentially useful discriminatory marker between intraductal papilloma and ductal carcinoma in situ.
Hoshikawa S; Sano T; Hirato J; Oyama T; Fukuda T
Cytopathology; 2016 Apr; 27(2):108-14. PubMed ID: 25810244
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of immunocytochemistry using a Breast Marker antibody cocktail targeting P63/cytokeratin7/18/cytokeratin5/14 for fine needle aspiration of the breast: a retrospective cohort study of 139 cases.
Tanaka S; Kanomata N; Teramura K; Wakita K; Kunihisa T; Yano Y; Moriya T; Hayashi Y
Cytopathology; 2016 Dec; 27(6):465-471. PubMed ID: 27060708
[TBL] [Abstract][Full Text] [Related]
19. Quantitative examination of mechanophysical tumor cell enrichment in fine-needle aspiration specimens.
Ernst LM; Rimm DL
Cancer; 2002 Oct; 96(5):275-9. PubMed ID: 12378594
[TBL] [Abstract][Full Text] [Related]
20. Value of scoring system in classification of proliferative breast disease on fine needle aspiration cytology.
Mridha AR; Iyer VK; Kapila K; Verma K
Indian J Pathol Microbiol; 2006 Jul; 49(3):334-40. PubMed ID: 17001879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
